205 related articles for article (PubMed ID: 27056978)
1. Inpp5e suppresses polycystic kidney disease via inhibition of PI3K/Akt-dependent mTORC1 signaling.
Hakim S; Dyson JM; Feeney SJ; Davies EM; Sriratana A; Koenig MN; Plotnikova OV; Smyth IM; Ricardo SD; Hobbs RM; Mitchell CA
Hum Mol Genet; 2016 Jun; 25(11):2295-2313. PubMed ID: 27056978
[TBL] [Abstract][Full Text] [Related]
2. AKT signaling promotes DNA damage accumulation and proliferation in polycystic kidney disease.
Conduit SE; Davies EM; Ooms LM; Gurung R; McGrath MJ; Hakim S; Cottle DL; Smyth IM; Dyson JM; Mitchell CA
Hum Mol Genet; 2020 Jan; 29(1):31-48. PubMed ID: 31625572
[TBL] [Abstract][Full Text] [Related]
3. β-catenin ablation exacerbates polycystic kidney disease progression.
Conduit SE; Hakim S; Feeney SJ; Ooms LM; Dyson JM; Abud HE; Mitchell CA
Hum Mol Genet; 2019 Jan; 28(2):230-244. PubMed ID: 30265301
[TBL] [Abstract][Full Text] [Related]
4. A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma.
Conduit SE; Ramaswamy V; Remke M; Watkins DN; Wainwright BJ; Taylor MD; Mitchell CA; Dyson JM
Oncogene; 2017 Oct; 36(43):5969-5984. PubMed ID: 28650469
[TBL] [Abstract][Full Text] [Related]
5. INPP5E regulates phosphoinositide-dependent cilia transition zone function.
Dyson JM; Conduit SE; Feeney SJ; Hakim S; DiTommaso T; Fulcher AJ; Sriratana A; Ramm G; Horan KA; Gurung R; Wicking C; Smyth I; Mitchell CA
J Cell Biol; 2017 Jan; 216(1):247-263. PubMed ID: 27998989
[TBL] [Abstract][Full Text] [Related]
6. Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys.
Baba M; Furihata M; Hong SB; Tessarollo L; Haines DC; Southon E; Patel V; Igarashi P; Alvord WG; Leighty R; Yao M; Bernardo M; Ileva L; Choyke P; Warren MB; Zbar B; Linehan WM; Schmidt LS
J Natl Cancer Inst; 2008 Jan; 100(2):140-54. PubMed ID: 18182616
[TBL] [Abstract][Full Text] [Related]
7. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase signaling determines kidney size.
Chen JK; Nagai K; Chen J; Plieth D; Hino M; Xu J; Sha F; Ikizler TA; Quarles CC; Threadgill DW; Neilson EG; Harris RC
J Clin Invest; 2015 Jun; 125(6):2429-44. PubMed ID: 25985273
[TBL] [Abstract][Full Text] [Related]
9. An mTOR kinase inhibitor slows disease progression in a rat model of polycystic kidney disease.
Ravichandran K; Zafar I; Ozkok A; Edelstein CL
Nephrol Dial Transplant; 2015 Jan; 30(1):45-53. PubMed ID: 25239638
[TBL] [Abstract][Full Text] [Related]
10. Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases.
Eramo MJ; Mitchell CA
Biochem Soc Trans; 2016 Feb; 44(1):240-52. PubMed ID: 26862211
[TBL] [Abstract][Full Text] [Related]
11. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
[TBL] [Abstract][Full Text] [Related]
12. Deletion of Aurora kinase A prevents the development of polycystic kidney disease in mice.
Tham MS; Cottle DL; Zylberberg AK; Short KM; Jones LK; Chan P; Conduit SE; Dyson JM; Mitchell CA; Smyth IM
Nat Commun; 2024 Jan; 15(1):371. PubMed ID: 38191531
[TBL] [Abstract][Full Text] [Related]
13. mTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex.
Pema M; Drusian L; Chiaravalli M; Castelli M; Yao Q; Ricciardi S; Somlo S; Qian F; Biffo S; Boletta A
Nat Commun; 2016 Mar; 7():10786. PubMed ID: 26931735
[TBL] [Abstract][Full Text] [Related]
14. INPP5E interacts with AURKA, linking phosphoinositide signaling to primary cilium stability.
Plotnikova OV; Seo S; Cottle DL; Conduit S; Hakim S; Dyson JM; Mitchell CA; Smyth IM
J Cell Sci; 2015 Jan; 128(2):364-72. PubMed ID: 25395580
[TBL] [Abstract][Full Text] [Related]
15. Effects of combining rapamycin and resveratrol on apoptosis and growth of TSC2-deficient xenograft tumors.
Alayev A; Salamon RS; Sun Y; Schwartz NS; Li C; Yu JJ; Holz MK
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):637-46. PubMed ID: 25844891
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress downstream of mTORC1 but not AKT causes a proliferative defect in cancer cells resistant to PI3K inhibition.
Dermit M; Casado P; Rajeeve V; Wilkes EH; Foxler DE; Campbell H; Critchlow S; Sharp TV; Gribben JG; Unwin R; Cutillas PR
Oncogene; 2017 May; 36(19):2762-2774. PubMed ID: 27991931
[TBL] [Abstract][Full Text] [Related]
17. mTOR signaling in polycystic kidney disease.
Ibraghimov-Beskrovnaya O; Natoli TA
Trends Mol Med; 2011 Nov; 17(11):625-33. PubMed ID: 21775207
[TBL] [Abstract][Full Text] [Related]
18. Effects of TORC1 Inhibition during the Early and Established Phases of Polycystic Kidney Disease.
Ta MH; Schwensen KG; Foster S; Korgaonkar M; Ozimek-Kulik JE; Phillips JK; Peduto A; Rangan GK
PLoS One; 2016; 11(10):e0164193. PubMed ID: 27723777
[TBL] [Abstract][Full Text] [Related]
19. Protease-activated receptor-2 promotes kidney tubular epithelial inflammation by inhibiting autophagy via the PI3K/Akt/mTOR signalling pathway.
Du C; Zhang T; Xiao X; Shi Y; Duan H; Ren Y
Biochem J; 2017 Aug; 474(16):2733-2747. PubMed ID: 28694352
[TBL] [Abstract][Full Text] [Related]
20. An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2.
Ravichandran K; Zafar I; He Z; Doctor RB; Moldovan R; Mullick AE; Edelstein CL
Hum Mol Genet; 2014 Sep; 23(18):4919-31. PubMed ID: 24847003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
